Detalles de la búsqueda
1.
Survival Advantage of Yttrium-90 Radioembolization to Systemic Therapy in Patients with Hepatic Metastases from Colorectal Cancer in the Salvage Setting: Results of a Matched Pair Study.
Acad Radiol
; 28 Suppl 1: S210-S217, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34099386
2.
Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety.
Immunotherapy
; 11(8): 705-723, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31045464
3.
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.
J Natl Cancer Inst
; 110(6): 638-648, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29267900
4.
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
J Clin Oncol
; 33(34): 4032-8, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26460303
5.
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database.
J Clin Oncol
; 33(1): 22-8, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25385741
6.
Improved imaging and the clinician: the role of positron emission tomography in the management of colorectal cancer.
Mol Imaging Biol
; 6(4): 208-13, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15262236
7.
Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer.
J Clin Oncol
; 28(27): 4240-6, 2010 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20713879
Resultados
1 -
7
de 7
1
Próxima >
>>